rVSV-Sudan

N/A

Report date: 2025/01/26 17:04:05

Base Information

Drug NamerVSV-Sudan

Drug Alias Namerecombinant Vesicular Stomatitis Virus-Sudan vaccine (recombinant viral vector) (Emergent Biosolutions)viral vector vaccine (Emergent Biosolutions)rVSV-Sudan vaccine (recombinant viral vector) (Emergent Biosolutions)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHemorrhagic Fever, Ebola

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUganda

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEmergent Biosolutions Inc

China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc

Inactive CompaniesN/A

Active IndicationsHemorrhagic Fever, Ebola

Inactive IndicationsN/A

Other Information

ATC CodeN/A